212 related articles for article (PubMed ID: 19131186)
1. Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma.
Haas RL; Girinsky T; Aleman BM; Henry-Amar M; de Boer JP; de Jong D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1199-202. PubMed ID: 19131186
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
3. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.
Regula DP; Hoppe RT; Weiss LM
N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412
[TBL] [Abstract][Full Text] [Related]
4. Nodular lymphocyte predominant Hodgkin's lymphoma.
Siddiqui N; Al-Diab AI
Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
[TBL] [Abstract][Full Text] [Related]
5. [Late recurrence of Hodgkin's disease 20 years after initial diagnosis. Personal observation of two cases and a literature review].
Marková J; Maaloufová J; Stríteský J; Feltl D; Kozák T
Vnitr Lek; 2002 Feb; 48(2):157-60. PubMed ID: 11949226
[TBL] [Abstract][Full Text] [Related]
6. Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin's disease.
Chadha M; Yoon H; Feldman S; Shah N; Moore E; Harrison LB
Am J Clin Oncol; 2009 Apr; 32(2):132-6. PubMed ID: 19307955
[TBL] [Abstract][Full Text] [Related]
7. [Relapse in Hodgkin's disease. Incidence of relapse in a group of 374 patients from 1 June 1968 to 31 March 1995].
Dienstbier Z; Hermanská Z; Zámecník J; Melínová L; Vacková B; Skala E; Srbová D
Vnitr Lek; 1995 Dec; 41(12):816-21. PubMed ID: 8600652
[TBL] [Abstract][Full Text] [Related]
8. The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience.
Olcese F; Clavio M; Rossi E; Spriano M; Ballerini F; Canepa L; Pierri I; Aquino S; Varaldo R; Manna A; Secondo V; Racchi O; Balleari E; Orcioni GF; Carella AM; Ghio R; Gobbi M
Ann Hematol; 2009 Sep; 88(9):855-61. PubMed ID: 19189105
[TBL] [Abstract][Full Text] [Related]
9. Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy.
Bischof M; Zierhut D; Neuhof D; Karagiozidis M; Treiber M; Roeder F; Debus J; Krempien R
Ophthalmologica; 2007; 221(5):348-52. PubMed ID: 17728558
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
11. [Results of radiotherapy in case of Hodgkin's disease after primary failure of chemotherapy and recurrence after chemotherapy ].
Gassmann W; Schmitz N; Breidenbach M; Haas R; Barth G; Pralle H; Löffler H
Strahlentherapie; 1982 Jun; 158(6):336-41. PubMed ID: 7123581
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of Hodgkin's disease after 25 years].
Dienstbier Z; Skala E; Blomannová E
Cas Lek Cesk; 2004; 143(3):184-6. PubMed ID: 15134038
[TBL] [Abstract][Full Text] [Related]
13. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
14. Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma.
Ng M; Wirth A; Ryan G; MacManus M; Davis S
Australas Radiol; 2006 Jun; 50(3):222-7. PubMed ID: 16732818
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients.
Sperotto A; Damiani D; Zaja F; Patriarca F; Geromin A; Cerno M; Stocchi R; Tiribelli M; Skert C; Rinaldi C; Fanin R
Adv Clin Path; 2002 Apr; 6(2):77-85. PubMed ID: 19753729
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease of the nasopharynx: diagnostic and therapeutic approach with a review of the literature.
Anselmo AP; Cavalieri E; Cardarelli L; Gianfelici V; Osti FM; Pescarmona E; Maurizi Enrici R
Ann Hematol; 2002 Sep; 81(9):514-6. PubMed ID: 12373352
[TBL] [Abstract][Full Text] [Related]
18. Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma.
Dhakal S; Biswas T; Liesveld JL; Friedberg JW; Phillips GL; Constine LS
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):188-92. PubMed ID: 19250770
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the recurrence pattern in Hodgkin's disease].
Lütgemeier J; Zerwes A
Strahlentherapie; 1985 Oct; 161(10):615-9. PubMed ID: 4060199
[TBL] [Abstract][Full Text] [Related]
20. [Subtotal body irradiation and its effectiveness in the treatment of patients with lymphogranulomatosis (first stage of therapy)].
Dudarev AL; Korytova LI; Ilín NV
Vestn Rentgenol Radiol; 1993; (5):43-5. PubMed ID: 7801583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
